Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Change in Acquisitions & Divestments (2016 - 2024)

Historic Change in Acquisitions & Divestments for Kyntra Bio (KYNB) over the last 11 years, with Q4 2024 value amounting to $1.7 million.

  • Kyntra Bio's Change in Acquisitions & Divestments fell 9834.39% to $1.7 million in Q4 2024 from the same period last year, while for Jun 2025 it was $1.7 million, marking a year-over-year decrease of 9951.22%. This contributed to the annual value of $133.8 million for FY2024, which is 6659.16% down from last year.
  • Latest data reveals that Kyntra Bio reported Change in Acquisitions & Divestments of $1.7 million as of Q4 2024, which was down 9834.39% from $72.2 million recorded in Q2 2024.
  • Over the past 5 years, Kyntra Bio's Change in Acquisitions & Divestments peaked at $156.0 million during Q2 2020, and registered a low of $42000.0 during Q1 2021.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $72.2 million (2024), whereas its average is $71.5 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first crashed by 9990.85% in 2021, then soared by 18109761.9% in 2022.
  • Kyntra Bio's Change in Acquisitions & Divestments (Quarter) stood at $155.0 million in 2020, then plummeted by 76.23% to $36.8 million in 2021, then surged by 84.94% to $68.1 million in 2022, then skyrocketed by 46.9% to $100.1 million in 2023, then plummeted by 98.34% to $1.7 million in 2024.
  • Its last three reported values are $1.7 million in Q4 2024, $72.2 million for Q2 2024, and $59.9 million during Q1 2024.